Commonwealth Coat of Arms of Australia

 

 

PB 10 of 2025

National Health (Price and Special Patient Contribution) Amendment Determination (No. 1) 2025

I, Rebecca Richardson, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:

Dated    30  January 2025

REBECCA RICHARDSON

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

Schedule 1—Amendments 2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

  This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination (No. 1) 2025.

  This instrument may also be cited as PB 10 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 February 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under section 85B of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1 – Amendments

 

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1.                  Schedule 1 – entry for Azathioprine

Omit

Azathioprine

Tablet 25 mg

Oral

Imuran

100

7.80

11.69

 

Tablet 50 mg

Oral

Imuran

100

13.29

17.18

Insert

Azathioprine

Tablet 25 mg

Oral

Imuran

100

7.80

13.38

 

Tablet 50 mg

Oral

Imuran

100

13.29

18.87

  1.                  Schedule 1 – after entry for Dabigatran etexilate

Insert

Desvenlafaxine

Tablet (extended release) 50 mg (as succinate)

Oral

Pristiq

28

6.45

9.24

 

Tablet (extended release) 100 mg (as succinate)

Oral

Pristiq

28

7.92

10.71

  1.                  Schedule 1 – after entry for Ezetimibe with atorvastatin

Insert

Ezetimibe with simvastatin

Tablet 10 mg-40 mg

Oral

Vytorin

30

8.70

10.56

 

Tablet 10 mg-80 mg

Oral

Vytorin

30

9.47

11.33

  1.                  Schedule 1 – after entry for Enalapril

Insert

Enalapril with hydrochlorothiazide

Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg

Oral

Renitec Plus 20/6

30

4.99

11.47

  1.                  Schedule 1 – entry for Fluconazole

Omit

Fluconazole

Capsule 50 mg

Oral

Diflucan

28

5.93

14.54

 

Capsule 100 mg

Oral

Diflucan

28

11.53

15.49

 

Capsule 200 mg

Oral

Diflucan

28

22.47

29.13

Insert

Fluconazole

Capsule 50 mg

Oral

Diflucan

28

5.93

14.54

 

Capsule 100 mg

Oral

Diflucan

28

11.53

23.62

 

Capsule 200 mg

Oral

Diflucan

28

22.47

40.61

  1.                  Schedule 1 – entry for Mometasone

Omit

Mometasone

Cream containing mometasone furoate 1 mg per g, 15 g

Application

Elocon Alcohol Free

1

3.50

6.78

 

Lotion containing mometasone furoate 1 mg per g, 30 mL

Application

Elocon

1

4.86

8.15

 

Ointment containing mometasone furoate 1 mg per g, 15 g

Application

Elocon

1

3.50

6.78

Insert

Mometasone

Cream containing mometasone furoate 1 mg per g, 15 g

Application

Elocon Alcohol Free

1

3.50

6.78

 

Lotion containing mometasone furoate 1 mg per g, 30 mL

Application

Elocon

1

4.86

9.05

 

Ointment containing mometasone furoate 1 mg per g, 15 g

Application

Elocon

1

3.50

6.78

 

  1.                  Schedule 1 – entry for Pregabalin

Omit

Pregabalin

Capsule 25 mg

Oral

Lyrica

56

3.73

5.71

 

Capsule 75 mg

Oral

Lyrica

56

4.68

9.20

 

Capsule 150 mg

Oral

Lyrica

56

7.19

12.72

 

Capsule 300 mg

Oral

Lyrica

56

10.72

12.58

Insert

Pregabalin

Capsule 25 mg

Oral

Lyrica

56

3.73

5.71

 

Capsule 75 mg

Oral

Lyrica

56

4.68

10.45

 

Capsule 150 mg

Oral

Lyrica

56

7.19

14.73

 

Capsule 300 mg

Oral

Lyrica

56

10.72

12.58